Stocks · Health care · Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc.

RARE Clue Score44

United States Fiscal year ends December CIK 0001515673 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$107.90K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$107.90K

1 of 1 sales

Net

−$107.90K

−$107.90K against sales at will